BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20647474)

  • 1. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.
    Li D; Abbruzzese JL
    Clin Cancer Res; 2010 Sep; 16(17):4313-8. PubMed ID: 20647474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
    Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
    J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and pancreatic cancer.
    Li D
    Mol Carcinog; 2012 Jan; 51(1):64-74. PubMed ID: 22162232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
    Yeo TP
    Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and pancreatic cancer.
    Cui Y; Andersen DK
    Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic therapies affect risk of pancreatic cancer.
    Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
    Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complexities of obesity and diabetes with the development and progression of pancreatic cancer.
    Bao B; Wang Z; Li Y; Kong D; Ali S; Banerjee S; Ahmad A; Sarkar FH
    Biochim Biophys Acta; 2011 Apr; 1815(2):135-46. PubMed ID: 21129444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
    Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
    J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
    Rozengurt E; Sinnett-Smith J; Kisfalvi K
    Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes.
    Antwi SO; Oberg AL; Shivappa N; Bamlet WR; Chaffee KG; Steck SE; Hébert JR; Petersen GM
    Carcinogenesis; 2016 May; 37(5):481-90. PubMed ID: 26905587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and pancreatic cancer.
    Muniraj T; Chari ST
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
    BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.
    Tseng CH
    Pancreas; 2018 Oct; 47(9):e57-e59. PubMed ID: 30199488
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.
    Pothuraju R; Rachagani S; Junker WM; Chaudhary S; Saraswathi V; Kaur S; Batra SK
    J Exp Clin Cancer Res; 2018 Dec; 37(1):319. PubMed ID: 30567565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer.
    Eibl G; Rozengurt E
    Cancer Metastasis Rev; 2021 Sep; 40(3):865-878. PubMed ID: 34142285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
    Herrigel DJ; Moss RA
    Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
    Gallagher EJ; LeRoith D
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention.
    Jansen RJ; Tan XL; Petersen GM
    Yale J Biol Med; 2015 Jun; 88(2):115-26. PubMed ID: 26029010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin may improve the prognosis of patients with pancreatic cancer.
    Zhang JW; Sun Q
    Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.